EIF2A and prostate carcinoma: PERK and eIF2α phosphorylation is suppressed in proliferative prostate cancer cells stimulated by androgens (Sheng et al, 2015), whereas ATF4 is essential for prostate cancer growth and survival (Pallmann et al, 2019).